TY - JOUR T1 - Estimating the genetically predicted effects of lifestyle risk factors, educational attainment and Alzheimer’s disease liability on weight change during midlife JF - medRxiv DO - 10.1101/2021.07.21.21260895 SP - 2021.07.21.21260895 AU - Grace M. Power AU - Jessica Tyrrell AU - Apostolos Gkatzionis AU - Si Fang AU - Jon Heron AU - George Davey Smith AU - Tom G. Richardson Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/07/30/2021.07.21.21260895.abstract N2 - Background Weight change is a major indicator of adverse health outcomes. This study aims to examine factors contributing to weight change over a one-year interval in midlife.Methods Observational and one-sample Mendelian randomisation (MR) analyses were conducted to estimate effects on weight change compared to one year previously (mean age: 56.5 years) using data from the UK Biobank study (n=453,169). Risk factors included alcohol consumption, smoking intensity, body mass index (BMI), educational attainment and Alzheimer’s disease liability.Results Observational analyses indicated strong evidence of an association between greater educational attainment and family history of Alzheimer’s disease with weight loss. In contrast, smoking intensity and higher BMI were associated with weight gain. MR analyses were consistent with observational estimates for educational attainment and Alzheimer’s disease liability on weight loss and provided strong evidence of a genetically predicted effect between higher overall BMI and weight gain. Whilst there was little evidence of a genetically predicted effect between smoking intensity and weight change in those who had ever smoked, when stratified, smoking intensity was associated with weight loss in current smokers and weight gain in previous smokers. There was little evidence of an association between alcohol consumption and weight change in the one-year period. Inverse probability weighting was used to account for non-random selection on smoking and alcohol status and further stratification by smoking status, indicating that our results were largely robust to collider bias.Conclusions Individuals who have been in education for longer, may have more opportunity to reduce their weight in midlife. The effect of Alzheimer’s disease liability on weight loss could be indicative of early signs of dementia. The relationship between smoking intensity and weight change is complex, reinforcing the importance of combining interventions aimed at controlling weight and smoking cessation among cigarette smokers.Key MessagesObservational and Mendelian randomisation analyses used in this study provide consistent evidence that educational attainment and Alzheimer’s disease liability have an effect on weight loss over one year during midlife.This suggests that individuals experiencing unintentional weight loss in midlife may be at high risk of developing Alzheimer’s disease in later life.These results additionally demonstrate the value of Mendelian randomisation in minimising spurious associations obtained through observational research when assessing lifestyle risk factors prone to residual confounding, such as smoking intensity.Our findings show that the relationship between smoking and weight change is complex, endorsing the notion that strategies to tackle weight control and smoking cessation should be combined.Competing Interest StatementRichardson has begun a part-time post with Novo Nordisk since this manuscript was initiated. The remaining authors have no disclosures to report.Funding StatementThis work was in part supported by the MRC Integrative Epidemiology Unit which receives funding from the UK Medical Research Council and the University of Bristol [MC_UU_00011/1]. Davey Smith conducts research at the National Institute for Health Research Biomedical Research Centre at the University Hospitals Bristol National Health Service (NHS) Foundation Trust and the University of Bristol. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health. Power is supported by the GW4 Biomed Doctoral Training Programme, awarded to the Universities of Bath, Bristol, Cardiff, and Exeter from the Medical Research Council /UK Research and Innovation [MR/N0137941/1]. Richardson was a UK Research and Innovation Research Fellow while contributing to this study [MR/S003886/1]. Tyrell is supported by an Academy of Medical Sciences Springboard award, which is supported by the Academy of Medical Sciences, the Wellcome Trust, GCRF, the Government Department of Business, Energy and Industrial Strategy, the British Heart Foundation and Diabetes UK [SBF004\1079]. Fang is supported by a Wellcome Trust PhD studentship in Molecular, Genetic and Lifecourse Epidemiology [108902/Z/15/Z]. Gkatzionis is supported by the UK Medical Research Council and the University of Bristol [MC_UU_00011/3].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data were obtained from the UKBB study, who have obtained ethics approval from the Research Ethics Committee (REC; approval number: 11/NW/0382) and informed consent from all participants enrolled in UKBB.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are all available from within the supplementary materials or publicly accessible from the resources cited.BMIBody mass indexIPWInverse Probability WeightingMRMendelian randomisationOLROrdinal logistic regressionUKBUK Biobank ER -